GlassScriptPhysician profile
Ryan Edward Strom
NPI 1114335973
$4,245.97
in general payments reported to CMS, 2019-2025
31 companies · $1,516 in 2025
The $1,516 reported for 2025 was more than what 87% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $246 · 2022: $669 · 2023: $819 · 2024: $996 · 2025: $1,516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,330.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $695.19 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Pfizer INC. | $586.96 | 2022-2025 | |
| Abbvie INC. | $523.05 | 2021-2025 | |
| Novo Nordisk INC | $301.92 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $236.59 | 2021-2025 | Trelegy Ellipta, Arexvy |
| Otsuka America Pharmaceutical, INC. | $206.31 | 2022-2025 | Rexulti |
| Lilly USA, LLC | $196.63 | 2023-2025 | Mounjaro, Emgality, Jardiance |
| Axsome Therapeutics, INC. | $188.17 | 2024-2025 | Auvelity, Sunosi |
| Exact Sciences Corporation | $167.10 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $154.84 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $107.47 | 2021-2025 | Gardasil 9, Vaxelis, Capvaxive |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $91.67 | 2024-2025 | Caplyta |
| E.R. Squibb & Sons, L.L.C. | $87.45 | 2023-2025 | Camzyos, Eliquis |
| Radius Health, INC. | $84.27 | 2024-2025 | Tymlos |
| Sumitomo Pharma America, INC. | $73.03 | 2025 | Gemtesa |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $70.70 | 2022-2025 | Evenity |
| Vanda Pharmaceuticals INC. | $63.15 | 2025 | Fanapt |
| Novartis Pharmaceuticals Corporation | $54.65 | 2022 | |
| Astellas Pharma US INC | $50.15 | 2021-2025 | Veozah |
| Abbott Laboratories | $49.53 | 2025 | Freestyle Libre 3 |
| Dexcom, INC. | $36.60 | 2024 | Dexcom G6 Transmitter |
| Hologic Sales and Service, LLC | $36.40 | 2022-2025 | Aptima |
| Takeda Pharmaceuticals U.S.A., INC. | $32.54 | 2021-2024 | Trintellix |
| Ucb, INC. | $30.54 | 2024 | Nayzilam |
| Cranial Technologies, INC | $20.61 | 2025 | Doc Band |
| Alexion Pharmaceuticals, INC. | $19.78 | 2021 | |
| Kyowa Kirin, INC. | $18.07 | 2024 | Crysvita |
| Actelion Pharmaceuticals US, INC. | $17.12 | 2025 | Uptravi, Opsumit |
| Alvogen INC | $16.63 | 2022 | |
| Abiomed | $15.74 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.11 | 2023 | Ofev |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Strom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.